Reach Us +44-3308187254


An Approach To A Clinical Trial Involving Natural Health Products | 13335
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

An approach to a clinical trial involving natural health products

International Summit on Clinical Pharmacy & Dispensing

Tapan K. Basu

Accepted Abstracts: Clinic Pharmacol Biopharmaceut

DOI: 10.4172/2167-065X.S1.004

Clinical efficacy of Natural Health Products (NHPs) of plant origin is often limited and variable. This is likely due to extracts used not being standardized. The roots, flowers, stems, leaves, and seeds of a plant could be used in a pruduct either in isolation or collectively, and called an ?extract?. The chemical constutuents, however, can differ quantitavely and qualitatively between different parts and some times different species of a plant. There also exists multiple biologically active components in a plant that work synnergistically. It is essential that these components are present in a product in their optimal amounts and proportions for the best effective clinical outcome. Because of these complexities, a clinical study design for a natural health product, meeting all criteria, becomes a challenge as opposed to a study design for a drug, which normally involves a single active component. Using Echinacea plant (a popular herbal plant, indigenous to North America) as example, this presentation will provide a critical evaluation of the validity of its clinical efficacy claims, and describe an approach to a randomized, double-blind placebo-controlled clinical trial, which was designed taking into account the complexicities that are involved in NHPs.